Sean A. McCarthy, CEO: CytomX Therapeutics CTMX Sell · Filed 24/03/21

Trade details

Type: Insider sale
Amount: $42,266.07
Shares · price: 20,223 sh · $2.09 a share
Held after: 524,481 sh
Stock: CytomX Therapeutics CTMX
Person: Sean A. McCarthyCEO
Trade date: 24/03/19
Filed: 24/03/21
Days to filing: 2 days

Sold 3.7% of holdings

Share of holding sold: 3.7%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/18~24/04/18

Sean A. McCarthy's recent trades

Sean A. McCarthyCEO
Sell10b5-1 planCytomX Therapeutics
Sell10b5-1 plan
CytomX Therapeutics
CTMX
$763.8K
118,969 sh
$763.8K
Filed 03/19
Traded 03/17
Sean A. McCarthyCEO
Sell10b5-1 planCytomX Therapeutics
Sell10b5-1 plan
CytomX Therapeutics
CTMX
$462.1K
101,793 sh
$462.1K
Filed 25/11/10
Traded 25/11/06
Sean A. McCarthyCEO
Planned sale10b5-1 planCytomX Therapeutics
Planned sale10b5-1 plan
CytomX Therapeutics
CTMX
$461.9K
101,793 sh
$461.9K
Filed 25/11/06
Traded 25/11/06
Sean A. McCarthyCEO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$149.3K
55,511 sh
$149.3K
Filed 25/06/17
Traded 25/06/16
Sean A. McCarthyCEO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$22.6K
37,656 sh
$22.6K
Filed 25/03/20
Traded 25/03/18